Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2303114120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Yiming Wan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794. Hauptthemen laut MEDLINE: DNA, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, HHS | National Institutes of Health, SUNY | SBU | Laufer Center for Physical and Quantitative Biology, Stony Brook University.
Abstract (Originalsprache)
Drug resistance continues to impede the success of cancer treatments, creating a need for experimental model systems that are broad, yet simple, to allow the identification of mechanisms and novel countermeasures applicable to many cancer types. To address these needs, we investigated a set of engineered mammalian cell lines with synthetic gene circuits integrated into their genome that evolved resistance to Puromycin. We identified DNA amplification as the mechanism underlying drug resistance in 4 out of 6 replicate populations. Triplex-forming oligonucleotide (TFO) treatment combined with Puromycin could efficiently suppress the growth of cell populations with DNA amplification. Similar observations in human cancer cell lines suggest that TFOs could be broadly applicable to mitigate drug resistance, one of the major difficulties in treating cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794.
- The Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY 11794.
- Department of Chemical and Biological Engineering, Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong Special Administrative Region 99…
- KromaTid, Inc., Longmont, CO 80501.
- Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794.
ORCID-Profile: Yiming Wan, Quanhua Mu, Rafał Krzysztoń, Christopher Helenek, Jiguang Wang, Gábor Balázsi
Förderung
- NIGMS NIH HHS
- HHS | National Institutes of Health
- SUNY | SBU | Laufer Center for Physical and Quantitative Biology, Stony Brook University
- Stony Brook Cancer Center
Zitieren
APA
Wan, Y., Mu, Q., Krzysztoń, R., Cohen, J., Coraci, D., Helenek, C., Tompkins, C., Lin, A., Farquhar, K., Cross, E., Wang, J., & Balázsi, G. (2023). Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2303114120
Vancouver
Wan Y, Mu Q, Krzysztoń R, Cohen J, Coraci D, Helenek C, et al. Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2303114120
BibTeX
@article{Wan2023,
author = {Wan, Yiming and Mu, Quanhua and Krzysztoń, Rafał and Cohen, Joseph and Coraci, Damiano and Helenek, Christopher and Tompkins, Christopher and Lin, Annie and Farquhar, Kevin and Cross, Erin and Wang, Jiguang and Balázsi, Gábor},
title = {Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2303114120}
}
EUVIMED